Xiaoming Li
Xiaoming Li, MD, Ph.D. is now a Professor and Director of the Department of Otolaryngology Head & Neck Surgery, Bethune International Peace Hospital, China. He is now the Head of the Surgical Head and Neck Oncology Section, the Chinese Otolaryngology Head and Neck Surgery Society. His special interest is the surgical management of head and neck cancers including tumor resection and one-stage reconstruction. His expertise in surgical salvage for advanced recurrent head and squamous cell carcinomas (HNSCC) is recognized in that he gave two special talks in round table sessions on reconstructive surgery for HNSCC and one keynote lecture on salvage surgery of recurrent HNSCC in recent two IFOS world congresses. Over the years, he conducted a series of studies on the clinicopathologic features of HNSCC, defining some important factors for predicting metastasis and recurrence. He also devotes himself to in-depth investigation on molecular aspects of tumor invasion and progression, and therapeutic resistance of HNSCC. He was a research scientist from 1999 to 2002 at the National Cancer Institute (NCI), NIH, USA. He was a visiting professor at several universities in the world. He published a paper in Nature in 2003 for the definition of a new pathway for TNF receptor signaling. His research work is now focusing on genetic manipulations of resistance of HNSCC to chemoradiation by targeting some genes and cell populations such as cancer stem cells.